X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
male (21) 21
aged (20) 20
female (19) 19
index medicus (17) 17
middle aged (14) 14
risk factors (12) 12
acute coronary syndrome (10) 10
prospective studies (10) 10
treatment outcome (9) 9
prognosis (8) 8
coronary heart disease (7) 7
greece - epidemiology (7) 7
incidence (7) 7
acute coronary syndrome - epidemiology (6) 6
adult (6) 6
cardiovascular disease (6) 6
heart-disease (6) 6
risk (6) 6
secondary prevention (6) 6
aged, 80 and over (5) 5
analysis (5) 5
care and treatment (5) 5
follow-up studies (5) 5
management (5) 5
myocardial-infarction (5) 5
pharmacology & pharmacy (5) 5
acute coronary syndrome - mortality (4) 4
acute coronary syndromes (4) 4
cladophora cellulose (4) 4
hypertension (4) 4
inflammation (4) 4
research (4) 4
stroke (4) 4
atrial fibrillation (3) 3
cardiac & cardiovascular systems (3) 3
cardiac patients (3) 3
cardiology (3) 3
cardiovascular-disease (3) 3
cellulose (3) 3
diabetes mellitus - epidemiology (3) 3
education (3) 3
electrocardiography (3) 3
emergency medicine (3) 3
guidelines (3) 3
health (3) 3
health aspects (3) 3
hospital mortality (3) 3
internal medicine (3) 3
life style (3) 3
logistic models (3) 3
mortality (3) 3
obesity (3) 3
peripheral vascular disease (3) 3
public health (3) 3
quality of life (3) 3
registry (3) 3
research article (3) 3
risk assessment (3) 3
severity of illness index (3) 3
socioeconomic-status (3) 3
surgery (3) 3
time factors (3) 3
abdomen (2) 2
abridged index medicus (2) 2
acetobacter-xylinum (2) 2
acute coronary syndrome - therapy (2) 2
acute disease (2) 2
acute myocardial-infarction (2) 2
adherence (2) 2
age distribution (2) 2
animals (2) 2
anticoagulants (2) 2
atherosclerosis (2) 2
atrial fibrillation - complications (2) 2
bacterial nanocellulose (2) 2
big data (2) 2
bioavailability (2) 2
biocompatibility (2) 2
biomaterials science (2) 2
biomaterialvetenskap (2) 2
biorelevant media (2) 2
biotechnology & applied microbiology (2) 2
cardiovascular (2) 2
cardiovascular diseases (2) 2
cell biology (2) 2
cellbiologi (2) 2
cellulose - metabolism (2) 2
cellulose nanofibers (2) 2
chondrocytes (2) 2
clinical medicine (2) 2
complications and side effects (2) 2
cross-sectional studies (2) 2
dermatology (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
diagnosis (2) 2
disease prevention (2) 2
electronic health records (2) 2
engineering and technology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 6/2016, Volume 105, Issue 6, pp. 518 - 526
Journal Article
Pharmaceutics, ISSN 1999-4923, 01/2020, Volume 12, Issue 1, p. 71
We have previously reported that heated powder mixtures of ibuprofen (IBU) and high surface area nanocellulose exhibit an enhanced dissolution and solubility... 
formulation | ibuprofen | amorphous | cladophora cellulose | polymorphs | biorelevant media
Journal Article
Applied Microbiology and Biotechnology, ISSN 0175-7598, 9/2014, Volume 98, Issue 17, pp. 7423 - 7435
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A11922 - A11922
IntroductionThe effect of income status on patient outcome merits investigation during periods of financial crisis.HypothesisWe evaluated the impact of income... 
Journal Article
International Journal of Recent Contributions from Engineering, Science & IT (iJES), ISSN 2197-8581, 03/2018, Volume 6, Issue 1, pp. 74 - 87
The aim of our research is to investigate the effects of traumatic experiences that teens with learning disorders had to go through. The sample of our study is... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article